Bionano Genomics Inc (BNGO)
1.11
-0.04
(-3.48%)
USD |
NASDAQ |
May 16, 16:00
1.10
-0.01
(-0.90%)
After-Hours: 20:00
Bionano Genomics Cash from Investing (Quarterly): 47.59M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 47.59M |
December 31, 2023 | -55.37M |
September 30, 2023 | 33.43M |
June 30, 2023 | 29.58M |
March 31, 2023 | 16.53M |
December 31, 2022 | 11.61M |
September 30, 2022 | 7.953M |
June 30, 2022 | 31.24M |
March 31, 2022 | 31.96M |
December 31, 2021 | -92.51M |
September 30, 2021 | -185.60M |
June 30, 2021 | 0.074M |
March 31, 2021 | -0.024M |
December 31, 2020 | 0.00 |
September 30, 2020 | -2.45M |
Date | Value |
---|---|
June 30, 2020 | 0.00 |
March 31, 2020 | 0.00 |
December 31, 2019 | -0.0231M |
September 30, 2019 | -0.008M |
June 30, 2019 | -0.03M |
March 31, 2019 | |
December 31, 2018 | -0.0118M |
September 30, 2018 | -0.1305M |
June 30, 2018 | -0.1776M |
March 31, 2018 | -0.0118M |
December 31, 2017 | -0.2818M |
September 30, 2017 | -0.2741M |
June 30, 2017 | -0.3904M |
March 31, 2017 | -0.0715M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-185.60M
Minimum
Sep 2021
47.59M
Maximum
Mar 2024
-6.303M
Average
--
Median
Mar 2020
Cash from Investing (Quarterly) Benchmarks
Bruker Corp | -304.20M |
Azenta Inc | -270.61M |
Harvard Bioscience Inc | -0.225M |
Akoya Biosciences Inc | -48.82M |
Singular Genomics Systems Inc | 0.651M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -28.13M |
Cash from Financing (Quarterly) | -21.62M |
Free Cash Flow | -122.26M |
Free Cash Flow Per Share (Quarterly) | -0.5339 |
Free Cash Flow to Equity (Quarterly) | 12.57M |
Free Cash Flow to Firm (Quarterly) | -28.16M |
Free Cash Flow Yield | -336.9% |